Sana Biotechnology (SANA) Net Cash Flow (2020 - 2026)

Sana Biotechnology's Net Cash Flow history runs 7 years deep, the most recent figure standing at $11.9 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 138.39% year-over-year to $11.9 million; the TTM figure through Mar 2026 stood at -$12.3 million (up 84.69% YoY), while the FY2025 annual figure was -$55.3 million, down 829.81% from the prior year.
• Net Cash Flow came in at $11.9 million for Q1 2026 at Sana Biotechnology, up from -$31.5 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $43.5 million in Q1 2024 to a low of -$64.5 million in Q1 2022.
• A 5-year average of -$10.2 million and a median of -$12.0 million in 2023 frame the typical range for Net Cash Flow.
• On a YoY basis, Net Cash Flow climbed as much as 502.99% in 2025 and fell as far as 5624.04% in 2025.
• Sana Biotechnology's Net Cash Flow stood at $13.4 million in 2022, then plunged by 360.25% to -$34.9 million in 2023, then surged by 101.63% to $570000.0 in 2024, then tumbled by 5624.04% to -$31.5 million in 2025, then jumped by 137.89% to $11.9 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered $11.9 million, -$31.5 million, and $32.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison